Developing a public health research agenda for women with blood disorders.
Bleeding and clotting in women is an issue that directly affects the life of every woman, child, and family worldwide. This article summarizes recent activities undertaken by the Division of Blood Disorders (DBD) at the Centers for Disease Control and Prevention (CDC) to identify risk factors through evidence-based research and surveillance to prevent complications of blood disorders in women. Specific focus is given to our efforts to improve early identification and diagnosis of blood disorders among women, improve our understanding of maternal and infant outcomes, and develop surveillance systems to monitor the prevalence and incidence of these events.
Byams
Vanessa R
VR
Division of Blood Disorders, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. vbyams@cdc.gov
Beckman
Michele G
MG
Grant
Althea M
AM
Parker
Christopher S
CS
D002487:Centers for Disease Control and Prevention, U.S.; D019317:Evidence-Based Medicine; D005260:Female; D006302:Health Services Research; D006402:Hematologic Diseases / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D011159:Population Surveillance; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D011256:Pregnancy Outcome; D012307:Risk Factors; D014481:United States